Miriam Saiz Rodríguez

Has grant

Associate Professor

Universidad de Burgos

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Medical Science Medical Science professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Miriam Saiz Rodríguez is an Associate Professor at Universidad de Burgos, Spain. Her research areas include pharmacogenetics, particularly focusing on the impact of genetic variations on drug responses in conditions such as diabetes, multiple myeloma, and acute myeloid leukemia. She has published extensively on topics like the pharmacogenetic factors influencing metformin response and biomarkers for various treatments.

Recent Grants

Grant: Close

Contrato Sara Borrell

Open Date: 2022-01-01

Close Date: 2025-01-01

Grant: Close

Grant for the hiring of research assistants and laboratory technicians co-financed by the European Social Fund through the Youth Employment Operational Program and the Initiative of Youth Employment (YEI).

Open Date: 2016-02-01

Close Date: 2018-01-01

Articles (11)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (4)

ISABEL CANO FERRI

Instituto de Investigación Sanitaria La Fe

SPAIN

View details

Francisco Abad-Santos

Professor

Universidad Complutense de Madrid Facultad de Medicina

SPAIN

View details

Maria Jose Herrero

University of Valencia

SPAIN

View details

Alberto M. Borobia

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Miriam Saiz Rodríguez

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (11)

Impact of CYP2D6 and CYP2B6 phenotypes on the response to tramadol in patients with acute post‐surgical pain

Identification of clinical and pharmacogenetic factors influencing metformin response in Type 2 diabetes mellitus

Bortezomib Pharmacogenetic Biomarkers for the Treatment of Multiple Myeloma: Review and Future Perspectives

Identification of Transporter Polymorphisms Influencing Metformin Pharmacokinetics in Healthy Volunteers

Pharmacogenetics in the Treatment of Huntington’s Disease: Review and Future Perspectives

Association Between Insulin-Like Growth Factor-1 and Social Cognition in Huntington's Disease.

Polymorphisms in the oxytocin receptor and their association with apathy and impaired social cognition in Huntington’s disease

Use of Venetoclax in Patients with Relapsed or Refractory Acute Myeloid Leukemia: The PETHEMA Registry Experience

Role of Pharmacogenetics in the Treatment of Acute Myeloid Leukemia: Systematic Review and Future Perspectives

Consensus of experts from the Spanish Pharmacogenetics and Pharmacogenomics Society and the Spanish Society of Medical Oncology for the genotyping of DPYD in cancer patients who are candidates for treatment with fluoropyrimidines

Use of Azacitidine or Decitabine for the Up-Front Setting in Acute Myeloid Leukaemia: A Systematic Review and Meta-Analysis

Collaborators (4)

ISABEL CANO FERRI

Francisco Abad-Santos

Maria Jose Herrero

Alberto M. Borobia

Make your next move.